XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Net service revenue $ 467,340 $ 399,262
Cost of service, excluding depreciation and amortization 275,274 238,309
General and administrative expenses:    
Salaries and benefits 94,830 75,631
Non-cash compensation 6,615 4,044
Other 43,402 41,680
Depreciation and amortization 2,895 3,593
Operating expenses 423,016 363,257
Operating income 44,324 36,005
Other income (expense):    
Interest income 24 120
Interest expense (3,349) (1,703)
Equity in earnings from equity method investments 1,216 1,860
Miscellaneous, net 236 601
Total other (expense) income, net (1,873) 878
Income before income taxes 42,451 36,883
Income tax expense (10,878) (9,563)
Net income 31,573 27,320
Net income attributable to noncontrolling interests (269) (161)
Net income attributable to Amedisys, Inc. $ 31,304 $ 27,159
Basic earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders, basic (usd per share) $ 0.98 $ 0.80
Weighted average shares outstanding, basic (shares) 32,001 33,971
Diluted earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders, diluted (usd per share) $ 0.95 $ 0.79
Weighted average shares outstanding, diluted (shares) 32,893 34,592